The objective of this study was to investigate the relationship between serum levels of specific biomarkers, such as presepsin, apelin, and irisin, and the clinical features, location, number, and size of lesions in patients suffering from cutaneous leishmaniasis. The gene discussed is FNDC5; the disease is cutaneous leishmaniasis.